Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janie Parrino

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|December 13, 2006
Smallpox vaccines: Past, present, and futureJanie Parrino, Barney S Graham
Emerging Infectious Diseases|May 8, 2007
Prevention of immune cell apoptosis as potential therapeutic strategy for severe infectionsJanie Parrino, Richard S Hotchkiss, Mike Bray
Rheumatology and Therapy|December 7, 2017
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid ArthritisAlan Kivitz, Lydie Baret-Cormel, Hubert van Hoogstraten, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical TrialMichael Eberhardson, Stephen Hall, Kim A Papp, et al.
The Journal of Infectious Diseases|May 20, 2015
Reply to DunningPeter B Gilbert, Erin E Gabriel, Michael G Hudgens, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
Clinical and Vaccine Immunology : CVI|July 13, 2012
Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjectsStephen K Tyring, Jon E Stek, Jeffrey G Smith, et al.
Vaccine|March 8, 2017
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodiesJanie Parrino, Shelly A McNeil, Steven J Lawrence, et al.
Rheumatology and Therapy|May 16, 2019
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic DrugsAlvin F Wells, Janie Parrino, Erin K Mangan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|December 13, 2006
Smallpox vaccines: Past, present, and futureJanie Parrino, Barney S Graham
Emerging Infectious Diseases|May 8, 2007
Prevention of immune cell apoptosis as potential therapeutic strategy for severe infectionsJanie Parrino, Richard S Hotchkiss, Mike Bray
Rheumatology and Therapy|December 7, 2017
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid ArthritisAlan Kivitz, Lydie Baret-Cormel, Hubert van Hoogstraten, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical TrialMichael Eberhardson, Stephen Hall, Kim A Papp, et al.
The Journal of Infectious Diseases|May 20, 2015
Reply to DunningPeter B Gilbert, Erin E Gabriel, Michael G Hudgens, et al.
Journal of Clinical Pharmacology|July 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable MethotrexateAnne J Paccaly, Pavel Kovalenko, Janie Parrino, et al.
Clinical and Vaccine Immunology : CVI|July 13, 2012
Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjectsStephen K Tyring, Jon E Stek, Jeffrey G Smith, et al.
Vaccine|March 8, 2017
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodiesJanie Parrino, Shelly A McNeil, Steven J Lawrence, et al.
Rheumatology and Therapy|May 16, 2019
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic DrugsAlvin F Wells, Janie Parrino, Erin K Mangan, et al.
Pageof 3